Central Nervous System Sarcoma
NCI Definition: A sarcoma that arises from the central nervous system. 
There are 2 clinical trials for central nervous system sarcoma, of which 2 are open and 0 are completed or closed. Of the trials that contain central nervous system sarcoma as an inclusion criterion, 2 are phase 2 (2 open).
Nivolumab and sunitinib are the most common interventions in central nervous system sarcoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.